| RS1445817375 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1445819062 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Alport syndrome, Hematuria |
| RS144582229 |
TECTA
|
Health Risk |
Conflicting classifications of pathogenicity |
TECTA-related disorder, TECTA-related disorder |
| RS1445826036 |
EARS2
|
Health Risk |
Pathogenic |
Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome, Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome |
| RS1445829303 |
CACNA1E
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 69 |
| RS144583275 |
PC
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS1445844416 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1445845736 |
MAK
|
Health Risk |
Pathogenic |
— |
| RS144585693 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS144586148 |
C8B
|
Health Risk |
Conflicting classifications of pathogenicity |
Type II complement component 8 deficiency, Inborn genetic diseases |
| RS144586270 |
TSPEAR
|
Health Risk |
Conflicting classifications of pathogenicity |
TSPEAR-related disorder, TSPEAR-related disorder |
| RS144586521 |
ANOS1
|
Health Risk |
Pathogenic |
— |
| RS144587211 |
IMPDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS144587241 |
F2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital prothrombin deficiency, Thrombophilia due to thrombin defect |
| RS144587343 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS144588417 |
HARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 3B, Usher syndrome type 3B |
| RS144588452 |
ABCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypoalphalipoproteinemia, primary |
| RS1445885320 |
KMT2C
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1445886162 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS1445887025 |
CNGB1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 45, Retinitis pigmentosa 45 |
| RS1445890457 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1445892049 |
GUCY2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 1, Cone-rod dystrophy 6 |
| RS1445893088 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS144589541 |
C3
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome with C3 anomaly, Complement component 3 deficiency |
| RS144590408 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS144590448 |
ITGB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukocyte adhesion deficiency 1, ITGB2-related disorder |
| RS144590560 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Congenital stationary night blindness autosomal dominant 2 |
| RS144590904 |
MTTP
|
Health Risk |
Conflicting classifications of pathogenicity |
Abetalipoproteinaemia, MTTP-related disorder |
| RS1445909096 |
RLBP1
|
Health Risk |
Likely pathogenic |
Newfoundland cone-rod dystrophy, Bothnia retinal dystrophy |
| RS144590958 |
PKD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS1445910672 |
TBX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tetralogy of Fallot, DiGeorge syndrome |
| RS144591360 |
ASL
|
Health Risk |
Conflicting classifications of pathogenicity |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS144592409 |
BLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 11, Maturity-onset diabetes of the young type 11 |
| RS144592743 |
DOK7
|
Health Risk |
Conflicting classifications of pathogenicity |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 10 |
| RS144592806 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, COL6A3-related disorder |
| RS144593192 |
IRF4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS144593342 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Polycystic kidney disease |
| RS1445940471 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group A, Fanconi anemia |
| RS144594692 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS144594695 |
EMD
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Emery-Dreifuss muscular dystrophy, Cardiovascular phenotype |
| RS144594804 |
SPAST
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 4, Spastic paraplegia |
| RS144594832 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
LRP2-related disorder, Donnai-Barrow syndrome |
| RS144594875 |
MTHFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS144595013 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS144595035 |
F11
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1445951068 |
ATP7B
|
Health Risk |
Pathogenic |
Wilson disease, Wilson disease |
| RS1445951268 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS1445957469 |
TMEM237
|
Health Risk |
Likely pathogenic |
Joubert syndrome 14, Joubert syndrome 14 |
| RS144595998 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS144596205 |
ENTREP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS144596211 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS144596374 |
TLR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Herpes simplex encephalitis, susceptibility to |
| RS1445965781 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS144596955 |
ADAMTS10
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1445970498 |
PDX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Monogenic Diabetes (Maturity Onset Diabetes Of The Young 4)/Neonatal Diabetes Mellitus, Maturity-onset diabetes of the young |
| RS1445972147 |
BBS1
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 1, Bardet-Biedl syndrome 1 |
| RS144597224 |
C2CD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Orofaciodigital syndrome type 14, Gastric cancer |
| RS144597480 |
TBX20
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1445978091 |
CC2D2A
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS144597856 |
POLR1D
|
Health Risk |
Conflicting classifications of pathogenicity |
POLR1D-related disorder, POLR1D-related disorder |
| RS144597913 |
LYST
|
Health Risk |
Conflicting classifications of pathogenicity |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS144598063 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1445986287 |
SDHAF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma and paraganglioma |
| RS144599077 |
DYSF
|
Health Risk |
Pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS1445993948 |
PHKG2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXc, Glycogen storage disease IXc |
| RS144599409 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS144599870 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS144600070 |
DNAJC21
|
Health Risk |
Conflicting classifications of pathogenicity |
Bone marrow failure syndrome 3, DNAJC21-related disorder |
| RS1446002589 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS144600401 |
MTTP
|
Health Risk |
Conflicting classifications of pathogenicity |
Abetalipoproteinaemia, MTTP-related disorder |
| RS144601090 |
PKP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular cardiomyopathy, Arrhythmogenic right ventricular dysplasia 9 |
| RS1446025324 |
UNC13D
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS144602736 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS144603433 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Endometrial carcinoma |
| RS144603589 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS144603824 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS144605831 |
SAMD9L
|
Health Risk |
Conflicting classifications of pathogenicity |
SAMD9L-related disorder, SAMD9L-related disorder |
| RS144606661 |
NHLRC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, NHLRC2-related disorder |
| RS1446078714 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS144607919 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS1446081294 |
FLG
|
Health Risk |
Likely pathogenic |
Dermatitis, atopic |
| RS144608959 |
ERCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 5, Cockayne syndrome type 2 |
| RS144609506 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1446095060 |
CPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital hyperammonemia, type I |
| RS144609655 |
NTRK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary insensitivity to pain with anhidrosis, Inborn genetic diseases |
| RS144610900 |
VCAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Vitreoretinopathy, Inborn genetic diseases |
| RS144610914 |
PIBF1
|
Health Risk |
Likely pathogenic |
Cephalocele, Joubert syndrome 33 |
| RS1446110883 |
LTBP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Glaucoma of childhood, Glaucoma of childhood |
| RS1446115570 |
UNC13D
|
Health Risk |
Likely pathogenic |
Autoinflammatory syndrome, Autoinflammatory syndrome |
| RS1446116085 |
ENG
|
Health Risk |
Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS144612641 |
CLCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myotonia, autosomal dominant form |
| RS144613015 |
PRKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1446132233 |
LEPR
|
Health Risk |
Likely pathogenic |
— |
| RS144613667 |
TMEM216
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 2, Meckel syndrome |
| RS144614070 |
SLX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group A |
| RS144614075 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 3 |
| RS144614838 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS144615318 |
COL9A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Epiphyseal dysplasia, multiple |
| RS144615326 |
NBAS
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1446153272 |
IMPG1
|
Health Risk |
Pathogenic |
— |